Full-Time

Associate Director

Provider Engagement, Oncology

Posted on 11/23/2025

Evolent

Evolent

1,001-5,000 employees

Delivers value-based care through analytics

Compensation Overview

$110k - $125k/yr

+ Bonus

Company Does Not Provide H1B Sponsorship

Remote in USA + 1 more

More locations: California, USA

Remote

Category
Business & Strategy (2)
,
Requirements
  • MUST RESIDE IN CALIFORNIA OR THE WEST REGION
  • Minimum 5+ years in oncology, holding leadership roles within oncology clinical service lines, and/or practice group, national oncology networks, or healthcare consulting/equivalent experience
  • Must demonstrate clinical acumen with proven experience in provider engagement, value-based care operations, and/or practice transformation
  • Strongly preferred oncology clinical experience (i.e., RN, NP)
  • Must demonstrate knowledge of healthcare delivery operations, population health management best practices with proven success leading initiatives across clinical, operational, and financial domains in complex healthcare environments
  • Demonstrated success managing clinical and administrative leadership relationships and driving clinical/operational change
  • Strong understanding of value-based care, healthcare delivery systems, and payment models
  • Proven ability to develop and present content to clinical and executive leaders
  • Highly skilled at influencing and facilitating change in complex healthcare environments
  • Strong analytical acumen with the ability to interpret data and drive action
  • Ability to manage multiple markets and prioritize work across diverse stakeholder groups
  • Excellent communication, negotiation, and relationship-building skills
  • Proficiency in Microsoft Office (Word, Excel, PowerPoint)
  • Ability to travel up to 25-30%
Responsibilities
  • Serve as the primary relationship owner for assigned oncology groups within your respective market(s)
  • Cultivate productive, trusted relationships with key executives—including C-level clinical and administrative leadership
  • Lead practice transformation initiatives to advance quality, efficiency, and patient outcomes in alignment with value-based care objectives, including various incentive models
  • Strategically build clinical and administrative leadership relationships to support business development activities across key health systems, oncology groups, and community practices
  • Use advanced analytics to inform engagement strategies, monitor performance, and identify opportunities for improvement
  • Utilize data-driven resources to run efficient/effective meetings and work sessions with oncology groups and all relevant subject matter experts both internal and external to Evolent
  • Partner with oncology group leadership to build change management processes and support the practice pull through activities needed to drive change at scale through effective project management
  • Influence clinical and operational changes through effective communication, facilitation, and influence with practice leadership, physicians, APPs, pharmacists, and practice administrators
  • Develop and deliver compelling leadership presentations to clinical and executive audiences to drive alignment and accountability
  • Manage multiple markets, prioritizing and scaling engagement efforts to optimize program impact
  • Quarterback initiatives and collaborate cross-functionally with internal teams (i.e., product, medical, pharmacy, strategic accounts), to support practice needs, launch new quality initiatives, and guide practices through various transformation enablers such as EMR integrations and incentive programs.
  • Facilitate oncology group education and training related to new quality initiatives, partnering with relevant Evolent clinical subject matter experts, rollout of new patient navigation and technology-driven engagement platforms, inclusive of practice workflows changes and EMR integrations.  and various technology integrations and platforms
  • Partner with Provider Engagement Market Managers to ensure successful adoption and engagement of Evolent’s solutions (i.e., prior authorization, clinical pathways) to ensure timely patient access to care and drive high provider satisfaction, measured by CSAT and NPS scores
  • Support the development and execution of innovative engagement opportunities such as regional clinical symposiums and local provider experience advisory panels
  • Own market level engagement strategy and collaborate with provider engagement market managers to ensure change management initiatives are successful and drive key performance indicators
  • Partner with Evolent Strategic Account teams and payer clients to align priorities and deliver high-quality provider network engagement, performance reporting, and present to health plans clients
  • Maintain detailed records of practice interactions, progress on transformation, initiatives, and market trends
  • Represent the organization at regional forums/clinical symposiums, conferences, and support business growth opportunities
Desired Qualifications
  • Strongly preferred oncology clinical experience (i.e., RN, NP)

Evolent Health helps healthcare organizations transition to value-based care by pairing technology, analytics, and clinical expertise to improve patient outcomes while lowering costs. It partners with health systems, physician groups, and health plans to deliver data-driven care coordination, population health management, and risk-adjustment services. The company’s offerings include software platforms, analytics, and clinical support that enable more efficient care delivery, shared savings programs, and performance-based incentives. Compared with competitors, Evolent emphasizes end-to-end collaboration with clients and a diversified client base, combining technology with hands-on clinical and operational expertise to drive measurable outcomes. Its goal is to help clients succeed in value-based models by delivering better patient care at lower total costs.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Arlington, Virginia

Founded

2011

Simplify Jobs

Simplify's Take

What believers are saying

  • Oncology launches with Highmark and Aetna drive $2.4-2.6B 2026 revenue guidance.
  • Performance Suite expansion generates over $200M annual revenue from new agreements.
  • Archie Mayani's 2026 appointment accelerates AI in prior authorizations and clinical support.

What critics are saying

  • 7x leverage and $398M Q4 2025 goodwill impairment trigger covenant breaches by mid-2027.
  • Q1 2026 6.9% revenue miss erodes confidence, limits capital access post-$145M notes.
  • Privia Health's 17.4% Q4 growth captures share as Evolent posts flat $468.7M revenue.

What makes Evolent unique

  • Evolent unifies oncology, cardiology, musculoskeletal solutions under single platform post-2023 rebrand.
  • Serves 41 million enrollees with clinician-led pathways and technology-enabled decision support.
  • Focuses exclusively on value-based specialty care after divesting primary care to Privia in 2025.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Flexible Work Hours

Hybrid Work Options

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

0%
Yahoo Finance
Mar 19th, 2026
Evolent appoints Archie Mayani as chief product officer to drive AI innovation in healthcare

Evolent Health has appointed Archie Mayani as chief product officer. Mayani brings over 20 years of experience in healthcare technology and AI innovation from roles at GHX, Change Healthcare, UnitedHealth Group and Amazon. Most recently, Mayani served as CPO at GHX, where she developed AI-powered capabilities for healthcare supply chains. At Change Healthcare, she led clinical decision support and revenue cycle platforms, focusing on reducing administrative burden in prior authorisation. During her time at Optum and UnitedHealth Group, she scaled value-based care programmes that improved Medicare STARS performance and reduced hospital utilisation. Mayani also served as global head of product and content operations for Amazon Prime Video. She has received multiple industry honours, including the Global CPO Award in 2025 and Inspiring Leader Award in 2023.

Yahoo Finance
Mar 7th, 2026
Evolent Health drops to $5.18 fair value on 7x leverage and $398M goodwill impairment

Evolent Health faces a shifting investment narrative after analysts reset expectations, with fair value estimates dropping from $8.50 to $5.18. The revision reflects concerns about reserves, leverage and margin visibility. Despite lowered price targets, Oppenheimer, BTIG, UBS, Citi, Truist and Canaccord maintain positive ratings, citing conservative reserving and new contracts as potential margin support. Analysts view new CFO Mario Ramos as bringing increased transparency. However, KeyBanc downgraded to Sector Weight, highlighting leverage at approximately 7x and limited EBITDA recovery visibility. Multiple firms reduced 2026-2028 earnings assumptions amid medical cost pressures and ACA exchange membership concerns. Evolent recorded a $398 million goodwill impairment for Q4 2025 and issued 2026 revenue guidance of $2.4 billion to $2.6 billion.

Yahoo Finance
Feb 25th, 2026
Evolent Health shares jump 20.7% on Q4 beat and strong 2026 revenue guidance

Evolent Health shares surged 20.7% after the healthcare solutions company reported fourth-quarter earnings that beat expectations and issued optimistic revenue guidance. The company posted non-GAAP earnings of $0.08 per share, significantly improved from a $0.02 per share loss a year earlier and ahead of analyst forecasts. Whilst quarterly revenue fell 27.5% year-on-year to $468.7 million, meeting expectations, investors focused on strong future guidance. Evolent projected full-year 2026 revenue between $2.4 billion and $2.6 billion, with the midpoint suggesting approximately 30% growth and nearly 5% above analyst estimates. The shares are trading at $3.15, down 19.2% year-to-date and 73.3% below their 52-week high of $11.79 from July 2025.

Pulse Nigeria
Sep 24th, 2025
Privia Health Acquires Evolent's ACO Business To Boost Value-Based Care

Privia Health acquires Evolent's ACO business to boost value-based care.

Healthcare Dive
Sep 24th, 2025
Privia acquires Evolent's value-based primary care unit for $100M

Privia Health is acquiring a value-based primary care business from Evolent Health as the physician enablement company continues to expand its care delivery network into new geographies.

INACTIVE